Event

Journal Club - Decision Making at Interims and DMCs (Joint DIA Event)

Joint PSI Pharmaceutical Statistics & DIA Statistics Community 

DIA Chair: Susan Duke, Manager, Benefit Risk Evaluation, GSK 

Speaker: Andreas Sashegyi, Research Advisor, Decision Sciences Lilly Corporate Center, Lilly
A Benefit-risk Model to Facilitate DMC-sponsor Communication and Decision Making
Andreas Sashegyi
Drug Information Journal, Vol. 45, pp. 749-757, 2011
Abstract | Paper+ | Slides


PSI Chair: Katherine Hutchinson, Head of Consultancy, Quanticate
Speaker: Sara Hughes, VP, Clinical Statistics, GSK
Informing the selection of futility stopping thresholds: case study from a late-phase clinical trial  
Sara Hughes, Robert L. Cuffe, Alfons Lieftucht and W. Garrett Nichols 
Pharmaceutical Statistics, Vol. 8, Issue 1, pp. 25-37, 2009
Abstract | Paper+ | Slides 


Discussant: Lisa LaVange, Director, Office of Biostatistics in the Office of Translational Sciences, FDA

+ Papers available to view from 5th June 2012 to 3rd July 2012.

For a flier advertising the event, please click here.
 

Upcoming Events

Joint PSI/EFSPI Visualisation SIG 'Wonderful Wednesday' Webinars

Date: The Second Wednesday of every Month Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.

PSI Career Young Virtual Event (Q4 2024)

Date: Tuesday 10th December 2024 This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.

PSI Journal Club: Group Sequential Designs

Date: Thursday 12th December 2024 Chaired by Jenny Devenport, join us to hear Andy Grieve and Zhiwei Zhang discuss their recent work on group sequential designs.

PSI Introduction to Industry Training (ITIT) Course - 2024/2025

Date: October 2024 - July 2025 An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.

PSI Training Course: Mixed Models and Repeated Measures

Dates: Monday 3rd February 2025: 08:30-13:00 BST Tuesday 4th February 2025: 08:30 - 13:00 BST Wednesday 5th February 2025: 08:30 - 13:00 BST Thursday 6th February 2025: 08:30 - 13:00 BST This course is presented through lectures and practical sessions using SAS code. It is suitable for statisticians working on clinical trials, who already have a good understanding of linear and generalised linear models.